Castle Biosciences Inc
- Last sale
- Nov 2, 2026 · -5.82%
- Market cap
- $1.08B
- 30.82M shares
- Filings
- 894
Q3 2026+3.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derived−22.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−2.5% FY25 yoy
- $1.08B
- —
- 2.9×
- 2.2×
- 0.37%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $344,229,000 | reported | |
| FY 2024 | 2024-12-31 | $332,069,000 | reported | |
| FY 2023 | 2023-12-31 | $219,788,000 | reported | |
| FY 2022 | 2022-12-31 | $137,039,000 | reported | |
| FY 2021 | 2021-12-31 | $94,085,000 | reported | |
| FY 2020 | 2020-12-31 | $62,649,000 | reported | |
| FY 2019 | 2019-12-31 | $51,865,000 | reported | |
| FY 2018 | 2018-12-31 | $22,786,000 | reported |
Segments
Products
LineFY2025ShareChange
Dermatologic$216.37M63%−15.8%
Non Dermatologic$127.86M37%+70.3%
Other———
Total$344.23M
Medical laboratories
Castle Biosciences Inc is the 10th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071
CompanyRevenueGrowthNet marginMarket cap
GHGuardant Health, Inc.$982.0M32.9%42.4%$20.9BCAICaris Life Sciences, Inc.$812.0M97.0%8.4%$6.9BVCYTVeracyte, Inc.$517.1M16.0%12.8%$2.0BCDNACareDx, Inc.$379.8M13.8%5.6%$4.4B
CSTLCastle Biosciences Inc (this company)$344.2M3.7%7.0%$1.1B
FLGTFulgent Genetics, Inc.$322.7M13.8%18.8%$693.9MBLLNBillionToOne, Inc.$305.1M100.0%2.4%$5.3BGRALGrail, Inc.$147.2M17.2%277.5%$5.5BMDXHMDxHealth SA$107.9M19.8%31.1%$7.2MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR